SPEEDX
10.5.2021 22:02:12 CEST | Business Wire | Press release
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, announced it has been awarded up to US $1.8 million from CARB-X, a global non-profit partnership dedicated to supporting research and development to address the rising threat of drug-resistant bacteria. SpeeDx represents the first Australian-based diagnostics company to receive CARB-X funding and a further $1.9 million will be available once the project reaches defined milestones. Funds will be used to develop a rapid test for the combined detection of Chlamydia trachomatis and Neisseria gonorrhoeae , while identifying antimicrobial resistance (AMR) of gonorrhea infections towards common antibiotic treatments. Chlamydia (CT) and gonorrhea (NG) are globally significant sexually transmitted infections with serious health complications if left untreated,1 and AMR NG is an urgent public health threat.2
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210510005228/en/
Current antibiotic susceptibility testing methods fail to offer timely and comprehensive susceptibility/resistance information, especially in resource-limited settings. SpeeDx aims to develop an affordable, fast (<60 mins), point-of-care test for the detection of bacteria that cause CT and NG, in addition to determining the susceptibility of NG to three cheap, orally administered, and accessible antibiotics: cefixime, ciprofloxacin, and azithromycin. SpeeDx will utilize their newly patented In Signia™ technology to both assess the presence of active bacterial infection and AMR status. SpeeDx is collaborating with QuantuMDx to port the test onto their Q-POC™ sample to answer qPCR & integrated microarray system - a small battery-powered, simple-to-use device suitable for remote settings.
“We are working closely with QuantuMDx to supply affordable and innovative diagnostics with the goal of significantly improving the standard of care and antibiotic stewardship in STI management,” said Colin Denver, SpeeDx CEO. “This project is an excellent application of our recently developed In Signia technology and the support from CARB-X for this venture will help accelerate this development and extend access in critical need areas.”
Jonathan O’Halloran, Chief Executive, QuantuMDx added: “Antimicrobial resistance is a global public health threat and requires a global response. With rapidly rising rates of AMR, it is no longer good enough to simply provide a pathogen ID, we must also determine what therapeutics the infection is resistant to and which ones the infection are sensitive to. Performing this all within a single assay, as the patient waits, will be transformational. We launch Q-POC™ - our rapid PCR diagnostic system - later this year and we’re looking forward to this, our first commercial collaboration, with SpeeDx.”
About SpeeDx
Founded in 2009, SpeeDx is an Australian-based private company with subsidiary offices in Austin and London, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. For more information on SpeeDx please see: https://plexpcr.com
About CARB-X
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University
and funding is provided by the Biomedical Advanced Research and Development Authority (BARDA),
part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the US Department of Health and Human Services, the Wellcome Trust
, a global charity based in the UK working to improve health globally, Germany’s Federal Ministry of Education and Research (BMBF),
the UK Department of Health and Social Care’s Global Antimicrobial Resistance Innovation Fund (GAMRIF)
, the Bill & Melinda Gates Foundation
, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID)
, part of the US National Institutes of Health (NIH). CARB-X is investing up to $480 million from 2016-2022 to support innovative antibiotics and other therapeutics, vaccines, and rapid diagnostics. CARB-X supports the world’s largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X is headquartered at Boston University School of Law. carb-x.org/
. Follow us on Twitter @CARB_X.
About QuantuMDx
QuantuMDx Group is an ambitious company with a global vision of empowering the world to control and eradicate disease by making transformative, quality point-of-care diagnostic technologies universally accessible. QuantuMDx has operations and strategic partnerships in the United States, Asia, Australasia, Europe and Africa – keeping it at the forefront of molecular diagnostics. For more information go to: www.quantumdx.com
References
- WHO, News Release: More than 1 million new curable sexually transmitted infections every day, 6 June 2016
- WHO, News Release: Antibiotic-resistant gonorrhoea on the rise, new drugs needed, 7 July 2017
View source version on businesswire.com: https://www.businesswire.com/news/home/20210510005228/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Reveals 265% ROI and 99.99% Reduction in Risk of Exposure to Addressable Breach Risk Costs According to Total Economic Impact Study3.2.2026 15:00:00 CET | Press release
Effectiveness of Yubico’s technology: $5.3 million Net Present Value and $7.3 million in total benefits over three years, driven by 80% faster authentication and reduced help desk burden Yubico (NASDAQ STOCKHOLM: YUBICO), a modern cybersecurity company and creator of the most secure passkeys, today announced the results of a commissioned Total Economic Impact™ (TEI) of Yubico YubiKeys study conducted by Forrester Consulting. The study, comprised of interviews with global enterprises with over 5,000 employees, found that a composite organization based on interviewed customers achieved a 265% return on investment (ROI) and a net present value (NPV) of $5.3 million over three years by replacing traditional multi-factor authentication (MFA) and one-time passwords (OTPs) with phishing-resistant YubiKeys. In an era of high-quality deepfakes and generative AI-driven extortion, the study shows a critical shift in cybersecurity: traditional MFA is no longer sufficient to stop modern MFA-bypass
Fitch Solutions Delivers AI-Ready Credit Data on Snowflake Marketplace3.2.2026 15:00:00 CET | Press release
Direct access to Fitch Ratings and dv01 datasets now available on Snowflake Marketplace to accelerate financial modeling Fitch Solutions, a leading global provider of insights, data, and analytics, today announced a collaboration with Snowflake, the AI Data Cloud company, to deliver Fitch’s comprehensive datasets on Snowflake Marketplace. This offering will enable market participants and clients to access and work with Fitch’s credit intelligence directly within Snowflake, supporting faster analysis and simpler integration across modern workflows. Fitch Ratings credit data and loan-level performance benchmark datasets from dv01, a Fitch Solutions company, covering the U.S. auto, consumer unsecured, and non-agency RMBS sectors, are now available on Snowflake Marketplace. Additional offerings will follow, including data from Sustainable Fitch, CreditSights, and BMI. Over time, this will enable clients to access all of Fitch Solutions' universe directly in Snowflake. “Data sits at the hea
SLB Awarded Integrated Development Contract for Mutriba Field in Kuwait3.2.2026 15:00:00 CET | Press release
Kuwait Oil Company awards SLB five-year contract for next stage of Mutriba field development Global technology company SLB (NYSE: SLB) today announced that Kuwait Oil Company has awarded SLB a $1.5 billion, five-year integrated contract for the Mutriba field in Kuwait, including design, development and production management. The work builds on SLB’s subsurface understanding of the Mutriba field to support development planning and execution across deeper, technically demanding reservoir conditions. The contract covers development of high-pressure, high-temperature reservoirs with sour conditions, reflecting an expanded scope and responsibility for SLB as work on the Mutriba field progresses. “This award reflects the strength of our long-standing partnership with Kuwait Oil Company and the trust built over decades of working together,” said Steve Gassen, executive vice president, Geographies, SLB. “As development of the Mutriba field moves into its next stage, we are taking on end-to-end
LF Chooses Rimini Street to Optimize ERP Support, Drive Innovation and Transform the Business3.2.2026 15:00:00 CET | Press release
Leading South Korean lifestyle brand turns to Rimini Support™ for its Oracle and SAP enterprise systems to achieve cost savings, improve quality and responsiveness and fund innovation Rimini Street, Inc., (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that LF, a leading lifestyle company in South Korea, has selected Rimini Support™ to optimize maintenance for SAP ECC 6.0 and Oracle Database systems. With Rimini Street, LF is enhancing operational stability and accelerating business innovation projects, leveraging cost savings achieved to fuel transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203604473/en/ LF Chooses Rimini Street to Optimize ERP Support, Drive Innovation and Transform the Business LF’s Journey to Premium Support for Less Founded in 1974, LF is a leader in South Korea’s fashion
CSG Helps Businesses Cut Fraud Losses by Up to 70% with CSG Payments Protection.ai3.2.2026 14:30:00 CET | Press release
AI-powered fraud detection solution enables near-real-time, cross-channel transaction monitoring to stop fraud without slowing legitimate payments As payments fraud accelerates with AI, businesses are racing to spot and block threats without slowing customers down. Today, CSG® (NASDAQ: CSGS) launched CSG Payments Protection.ai, a next-generation fraud detection and financial risk management solution to accurately identify and stop payment fraud. The solution proactively monitors digital transactions across diverse payment channels and fraud types, so businesses can reduce fraud losses by 50–70% while significantly lowering false-positive alerts and the resulting customer friction. “Fraud is no longer a once-in-a-while surprise,” said Saurabh Joshi, EVP and President, CSG Payments. “It’s constant, adaptive, and affects businesses regardless of size or industry. That’s why it was so important for us to offer an always‑learning AI solution that can help businesses stay ahead of increasing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom